-
2
-
-
0036083301
-
Mechanism of action of antitumor drugs that interact with microtubules and tubulin
-
Jordan MA. Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr Med Chem Anticancer Agents 2002;1:1-17.
-
(2002)
Curr Med Chem Anticancer Agents
, vol.1
, pp. 1-17
-
-
Jordan, M.A.1
-
3
-
-
0036850914
-
Discovery and development of antimitotic agents that inhibit tubulin polymerization for treatment of cancer
-
Li Q, Sham HL. Discovery and development of antimitotic agents that inhibit tubulin polymerization for treatment of cancer. Exp Opin Ther Pat 2002;12:1663-1702.
-
(2002)
Exp Opin Ther Pat
, vol.12
, pp. 1663-1702
-
-
Li, Q.1
Sham, H.L.2
-
4
-
-
0036902919
-
Recent advances in the field of tubulin polymerization inhibitors
-
Prinz H. Recent advances in the field of tubulin polymerization inhibitors. Exp Rev Anticancer Ther 2002;2:695-708.
-
(2002)
Exp Rev Anticancer Ther
, vol.2
, pp. 695-708
-
-
Prinz, H.1
-
5
-
-
0242386588
-
Natural, semisynthetic and synthetic microtubule inhibitors for cancer therapy, and references therein
-
Beckers T, Mahboobi S. Natural, semisynthetic and synthetic microtubule inhibitors for cancer therapy, and references therein. Drugs Fut 2003;28:767-785.
-
(2003)
Drugs Fut
, vol.28
, pp. 767-785
-
-
Beckers, T.1
Mahboobi, S.2
-
8
-
-
0026344562
-
The chemistry of taxol
-
Kingston DG. The chemistry of taxol. Pharm Ther 1991;52:1-34.
-
(1991)
Pharm Ther
, vol.52
, pp. 1-34
-
-
Kingston, D.G.1
-
9
-
-
0018387446
-
Promotion of microtubule assembly in vitro by taxol
-
Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979;277:665-667.
-
(1979)
Nature
, vol.277
, pp. 665-667
-
-
Schiff, P.B.1
Fant, J.2
Horwitz, S.B.3
-
10
-
-
0029776766
-
Epothilone A and B-Novel 16-membered macrolides with cytotoxic activity. Isolation, crystal structure and conformation in solution
-
Hoefle G, Bedorf N, Steimetz H, Schomburg D, Gerth K, Reichenbach H. Epothilone A and B-Novel 16-membered macrolides with cytotoxic activity. Isolation, crystal structure and conformation in solution. Angew Chem Int Ed Engl 1996;35:1567-1569.
-
(1996)
Angew Chem Int Ed Engl
, vol.35
, pp. 1567-1569
-
-
Hoefle, G.1
Bedorf, N.2
Steimetz, H.3
Schomburg, D.4
Gerth, K.5
Reichenbach, H.6
-
11
-
-
0023710155
-
New potent cytotoxic macrolides from a marine sponge and a nudibranch predator
-
Corley DG, Herb R, Moore RE, Scheur PG, Paul VJ. Laulimalide. New potent cytotoxic macrolides from a marine sponge and a nudibranch predator. J Org Chem 1988;53:3644-3646.
-
(1988)
J Org Chem
, vol.53
, pp. 3644-3646
-
-
Corley, D.G.1
Herb, R.2
Moore, R.E.3
Scheur, P.G.4
Paul, V.J.5
Laulimalide6
-
12
-
-
0030039669
-
Discodermolide, cytotoxyc marine agent that stabilizes microtubules more potently than Taxol
-
(a) Ter Haar E, Kowalski RJ, Hamel E, et al. Discodermolide, cytotoxyc marine agent that stabilizes microtubules more potently than Taxol. Biochemistry 1996;35:243-250.
-
(1996)
Biochemistry
, vol.35
, pp. 243-250
-
-
Ter Haar, E.1
Kowalski, R.J.2
Hamel, E.3
-
13
-
-
0035802349
-
A pratical synthesisi of (+)-discodermolide and analogues: Fragment union by complex aldol reactions
-
(b) Paterson I, Florence GJ, Gerlach K, Scott JP, Sereinig N. A pratical synthesisi of (+)-discodermolide and analogues: Fragment union by complex aldol reactions. J Am Chem Soc 2001;23:9535-9544.
-
(2001)
J Am Chem Soc
, vol.23
, pp. 9535-9544
-
-
Paterson, I.1
Florence, G.J.2
Gerlach, K.3
Scott, J.P.4
Sereinig, N.5
-
16
-
-
0034773326
-
Vinflumine, the latest vinca alkaloid in clinical development. A review of its preclinical anticancer properties
-
Kruczynski A, Hill BT. Vinflumine, the latest vinca alkaloid in clinical development. A review of its preclinical anticancer properties. Crit Rev Oncol Hematol 2001;40:159-173.
-
(2001)
Crit Rev Oncol Hematol
, vol.40
, pp. 159-173
-
-
Kruczynski, A.1
Hill, B.T.2
-
17
-
-
3943060241
-
Vinflumine: Antimitotic vinca alkaloid
-
Mcintyre JA, Castaner J. Vinflumine: Antimitotic vinca alkaloid. Drugs Fut 2004;29:574-580.
-
(2004)
Drugs Fut
, vol.29
, pp. 574-580
-
-
Mcintyre, J.A.1
Castaner, J.2
-
18
-
-
0037061593
-
Biological activity of Tryprostatins and their diastereoisomers on human carcinoma cell lines
-
Zhao S, Smith KS, Deveau AM, Dieckhaus CM, Johnson MA, Macdonald TL, Cook JM. Biological activity of Tryprostatins and their diastereoisomers on human carcinoma cell lines. J Med Chem 2002;45:1559-1562.
-
(2002)
J Med Chem
, vol.45
, pp. 1559-1562
-
-
Zhao, S.1
Smith, K.S.2
Deveau, A.M.3
Dieckhaus, C.M.4
Johnson, M.A.5
Macdonald, T.L.6
Cook, J.M.7
-
19
-
-
0032143275
-
-
Usui T, Kondoh M, Cui CB, Mayumi T, Osada H. Tryprostatin A, a specific and novel inhibitor of microtubule assembly. Biochemical J 1998;333:543-563.
-
Usui T, Kondoh M, Cui CB, Mayumi T, Osada H. Tryprostatin A, a specific and novel inhibitor of microtubule assembly. Biochemical J 1998;333:543-563.
-
-
-
-
20
-
-
0034611441
-
Antimitotic activity of moroidin, a bicyclic peptide from the seeds of Celosia argentea
-
Morita H, Shimbo K, Shigemori H, Kobayashi J. Antimitotic activity of moroidin, a bicyclic peptide from the seeds of Celosia argentea. Bioorg Med Chem Lett 2000;10:469-471.
-
(2000)
Bioorg Med Chem Lett
, vol.10
, pp. 469-471
-
-
Morita, H.1
Shimbo, K.2
Shigemori, H.3
Kobayashi, J.4
-
21
-
-
0035812722
-
Celogentins A-C, new antimitotic bicyclic peptides from the seeds of Celosia argentea
-
Kobayashi J, Suzuki H, Shimbo K, Takeya K, Morita H. Celogentins A-C, new antimitotic bicyclic peptides from the seeds of Celosia argentea. J Org Chem 2001;66:6626-6633.
-
(2001)
J Org Chem
, vol.66
, pp. 6626-6633
-
-
Kobayashi, J.1
Suzuki, H.2
Shimbo, K.3
Takeya, K.4
Morita, H.5
-
22
-
-
4444352764
-
1,3-dimethyl- L-valinamide (HTI-286)
-
1,3-dimethyl- L-valinamide (HTI-286). J Med Chem 2004;47:4774-4786.
-
(2004)
J Med Chem
, vol.47
, pp. 4774-4786
-
-
Zask, A.1
Birnberg, G.2
Cheung, K.3
Kaplan, J.4
Niu, C.5
Norton, E.6
Suayan, R.7
Yashimita, A.8
Cole, D.9
-
23
-
-
0025904512
-
Isolation and structure determination of diazonamides A and B, unusual cytotoxic metabolites from the marine ascidian Diazona chinensis
-
Lindquist N, Fenical W, van Duyne GD, Clardy J. Isolation and structure determination of diazonamides A and B, unusual cytotoxic metabolites from the marine ascidian Diazona chinensis. J Am Chem Soc 1991;113:2303-2304.
-
(1991)
J Am Chem Soc
, vol.113
, pp. 2303-2304
-
-
Lindquist, N.1
Fenical, W.2
van Duyne, G.D.3
Clardy, J.4
-
24
-
-
1442310087
-
A tale of two tumor targets: Topoisoimerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy
-
Cragg GM, Newman DJ. A tale of two tumor targets: Topoisoimerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy. J Nat Prod 2004;67:232-244.
-
(2004)
J Nat Prod
, vol.67
, pp. 232-244
-
-
Cragg, G.M.1
Newman, D.J.2
-
25
-
-
0021061705
-
Interactions of combretatstatin, a new plant-derived antimitotic agent with tubulin
-
(a) Hamel E, Lin CM. Interactions of combretatstatin, a new plant-derived antimitotic agent with tubulin. Biochem Pharmacol 1983;32:3864-3867.
-
(1983)
Biochem Pharmacol
, vol.32
, pp. 3864-3867
-
-
Hamel, E.1
Lin, C.M.2
-
26
-
-
0024427745
-
Antimitotic natural products combretastatin A-4 and combretastatin A-2. Studies on the mechanism of their inhibition of the binding of colchicine tu tubulin
-
(b) Lin CM, Ho MM, Pettit GR, Hamel E. Antimitotic natural products combretastatin A-4 and combretastatin A-2. Studies on the mechanism of their inhibition of the binding of colchicine tu tubulin. Biochemistry 1998;28:6984-6991.
-
(1998)
Biochemistry
, vol.28
, pp. 6984-6991
-
-
Lin, C.M.1
Ho, M.M.2
Pettit, G.R.3
Hamel, E.4
-
27
-
-
13044294012
-
Selective, covalent modification of beta-tubulin residue Cys239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors
-
Shan B, Medina JC, Santha E, Frankmoelle WP, Chou TC, Learned RM, Narbut MR, Stott D, Wu P, Jaen JC, Rosen T, Timmermans PB, Beckmann H. Selective, covalent modification of beta-tubulin residue Cys239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. Proc Nat Acad Sci USA 1999;96:5686-5891.
-
(1999)
Proc Nat Acad Sci USA
, vol.96
, pp. 5686-5891
-
-
Shan, B.1
Medina, J.C.2
Santha, E.3
Frankmoelle, W.P.4
Chou, T.C.5
Learned, R.M.6
Narbut, M.R.7
Stott, D.8
Wu, P.9
Jaen, J.C.10
Rosen, T.11
Timmermans, P.B.12
Beckmann, H.13
-
28
-
-
0028331925
-
2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site
-
D'Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Nat Acad Sci USA 1994;91:3964-3968.
-
(1994)
Proc Nat Acad Sci USA
, vol.91
, pp. 3964-3968
-
-
D'Amato, R.J.1
Lin, C.M.2
Flynn, E.3
Folkman, J.4
Hamel, E.5
-
29
-
-
0027880193
-
Phase I trial of erbulozole (R55104)
-
Van Belle SJ, Distelmans W, Vandebroek J, Bruynseels J, Van Ginckel R, Storme GA. Phase I trial of erbulozole (R55104). Anticancer Res 1993;13:2389-2391.
-
(1993)
Anticancer Res
, vol.13
, pp. 2389-2391
-
-
Van Belle, S.J.1
Distelmans, W.2
Vandebroek, J.3
Bruynseels, J.4
Van Ginckel, R.5
Storme, G.A.6
-
30
-
-
33847121023
-
-
Haga T, Yamada N, Sugi H, Koyanagi T, Okada H, Ishihara Y. Preparation and formulation of (pyrimidinyloxyphenyl)benzoylureas as antitumor agents. Eur Pat Appl 1991; EP 413977
-
Haga T, Yamada N, Sugi H, Koyanagi T, Okada H, Ishihara Y. Preparation and formulation of (pyrimidinyloxyphenyl)benzoylureas as antitumor agents. Eur Pat Appl 1991; EP 413977.
-
-
-
-
31
-
-
0035282634
-
Antimitotic antitumor agents: Synthesis, structure-activity relationships, and biological characterization of N-aryl-N′-(2-chloroethyl)ureas as new selective alkylating agents
-
Mounetou E, Legault J, Lacroix J, C-Gaudreault R. Antimitotic antitumor agents: Synthesis, structure-activity relationships, and biological characterization of N-aryl-N′-(2-chloroethyl)ureas as new selective alkylating agents. J Med Chem 2001;44:694-702.
-
(2001)
J Med Chem
, vol.44
, pp. 694-702
-
-
Mounetou, E.1
Legault, J.2
Lacroix, J.3
C-Gaudreault, R.4
-
32
-
-
33847154384
-
-
Yoshino H, Ueda N, Niijima J, Haneda T, Kotake Y, Yoshimatsu K, Watanabe T, Nagasu T, Tsukahara N, et al. Preparation of sulfonamide and sulfonic ester derivatives each having tricyclic heterocyclic ring as antitumor agents. PCT Int Appl 1995; WO9503279.
-
Yoshino H, Ueda N, Niijima J, Haneda T, Kotake Y, Yoshimatsu K, Watanabe T, Nagasu T, Tsukahara N, et al. Preparation of sulfonamide and sulfonic ester derivatives each having tricyclic heterocyclic ring as antitumor agents. PCT Int Appl 1995; WO9503279.
-
-
-
-
33
-
-
17944366045
-
Design, synthesis and antiproliferative activity of tripentones: A new series of antitubulin agents
-
(a) Lisowski V, Enguehard C, Lancelot J-C, Caignard D-H, Lambel S, Leonce S, Pierre A, Atassi G, Renard P, Rault S. Design, synthesis and antiproliferative activity of tripentones: A new series of antitubulin agents. Bioorg Med Chem Lett 2001;16:2205-2208.
-
(2001)
Bioorg Med Chem Lett
, vol.16
, pp. 2205-2208
-
-
Lisowski, V.1
Enguehard, C.2
Lancelot, J.-C.3
Caignard, D.-H.4
Lambel, S.5
Leonce, S.6
Pierre, A.7
Atassi, G.8
Renard, P.9
Rault, S.10
-
34
-
-
1542358004
-
Design, synthesis, and evaluation of novel thienopyrrolizinones as antitubulin agents
-
(b) Lisowski V, Leonce S, Kraus-Berthier L, Santos JS-de O, Pierre A, Atassi G, Caignard D-H, Renard P, Rault S. Design, synthesis, and evaluation of novel thienopyrrolizinones as antitubulin agents. J Med Chem 2004;47:1448-1464.
-
(2004)
J Med Chem
, vol.47
, pp. 1448-1464
-
-
Lisowski, V.1
Leonce, S.2
Kraus-Berthier, L.3
Santos JS-de, O.4
Pierre, A.5
Atassi, G.6
Caignard, D.-H.7
Renard, P.8
Rault, S.9
-
35
-
-
0030756156
-
Mechanism of action of E-7010, an orally active sulfonamide antitumor agents: Inhibition of mitosis by binding to the colchicine site of tubulin
-
Yoshimatsu K, Yamaguchi A, Yoshino H, Koyanagi N, Kitoh K. Mechanism of action of E-7010, an orally active sulfonamide antitumor agents: Inhibition of mitosis by binding to the colchicine site of tubulin. Cancer Res 1997;57:3208-3213.
-
(1997)
Cancer Res
, vol.57
, pp. 3208-3213
-
-
Yoshimatsu, K.1
Yamaguchi, A.2
Yoshino, H.3
Koyanagi, N.4
Kitoh, K.5
-
36
-
-
0032481002
-
Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization
-
Gastpar R, Goldbrunner M, Marko D, von Angerer E. Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization. J Med Chem 1998;41:4965-4972.
-
(1998)
J Med Chem
, vol.41
, pp. 4965-4972
-
-
Gastpar, R.1
Goldbrunner, M.2
Marko, D.3
von Angerer, E.4
-
37
-
-
0030668053
-
Inhibition of tubulin polymerization by 5,6-5,6-dihydroindolo[2,1-a]isoquinoline derivatives
-
Goldbrunner M, Loidl M, Polossek T, Mannschreck A, von Angerer E. Inhibition of tubulin polymerization by 5,6-5,6-dihydroindolo[2,1-a]isoquinoline derivatives. J Med Chem 1997;40:3524-3533.
-
(1997)
J Med Chem
, vol.40
, pp. 3524-3533
-
-
Goldbrunner, M.1
Loidl, M.2
Polossek, T.3
Mannschreck, A.4
von Angerer, E.5
-
38
-
-
0001823765
-
Synthesis and antineoplastic activity of combretastatin analogues, heterocombretastatins
-
Medarde M, Ramos A, Caballero E, Peláez-Lamamié de Clariac R, López JL, García Grávalos D, San Feliciano A. Synthesis and antineoplastic activity of combretastatin analogues, heterocombretastatins. Eur J Med Chem 1998;33:71-77.
-
(1998)
Eur J Med Chem
, vol.33
, pp. 71-77
-
-
Medarde, M.1
Ramos, A.2
Caballero, E.3
Peláez-Lamamié de Clariac, R.4
López, J.L.5
García Grávalos, D.6
San Feliciano, A.7
-
39
-
-
0023801309
-
Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: A structure-activity study
-
Lin CM, Singh SB, Chu PS, Dempcey R, Smith JM, Petit GR, Hamel E. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: A structure-activity study. Mol Pharmacol 1988;34:200-208.
-
(1988)
Mol Pharmacol
, vol.34
, pp. 200-208
-
-
Lin, C.M.1
Singh, S.B.2
Chu, P.S.3
Dempcey, R.4
Smith, J.M.5
Petit, G.R.6
Hamel, E.7
-
40
-
-
0033575722
-
Synthesis and pharmacological activity of diarylindole derivatives, cytotoxic agents based on combretastatins
-
Medarde M, Ramos AC, Caballero E, Peláez-Lamamié de Clariac R, López JL, García Grávalos D, San Feliciano A. Synthesis and pharmacological activity of diarylindole derivatives, cytotoxic agents based on combretastatins. Bioorg Med Chem Lett 1999;9:2303-2308.
-
(1999)
Bioorg Med Chem Lett
, vol.9
, pp. 2303-2308
-
-
Medarde, M.1
Ramos, A.C.2
Caballero, E.3
Peláez-Lamamié de Clariac, R.4
López, J.L.5
García Grávalos, D.6
San Feliciano, A.7
-
41
-
-
0030272619
-
Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents
-
Haar E, Rosenkranz HS, Hamel E, Day BW. Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents. Bioorg Med Chem 1996;4:1659-1671.
-
(1996)
Bioorg Med Chem
, vol.4
, pp. 1659-1671
-
-
Haar, E.1
Rosenkranz, H.S.2
Hamel, E.3
Day, B.W.4
-
42
-
-
0031836174
-
Recent progress in the development of tubulin inhibitors as antimitotic antitumor agents
-
Shi Q, Chen K, Morris-Natschke SL, Lee K-H. Recent progress in the development of tubulin inhibitors as antimitotic antitumor agents. Current Pharm Design 1998;4:219-248.
-
(1998)
Current Pharm Design
, vol.4
, pp. 219-248
-
-
Shi, Q.1
Chen, K.2
Morris-Natschke, S.L.3
Lee, K.-H.4
-
43
-
-
0035924236
-
-
Mahboobi S, Pongratz H, Hufsky H, Hockenmeyer J, Frieser M, Lyssenko A, Paper DH, Burgmeister J, Böhmer F-D, Fiebig H-H, Burger AM, Baasner S, Beckers T. Synthetis 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents. J Med Chem 2001;44:4535-4553.
-
Mahboobi S, Pongratz H, Hufsky H, Hockenmeyer J, Frieser M, Lyssenko A, Paper DH, Burgmeister J, Böhmer F-D, Fiebig H-H, Burger AM, Baasner S, Beckers T. Synthetis 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents. J Med Chem 2001;44:4535-4553.
-
-
-
-
44
-
-
0036606778
-
2-Aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors
-
Beckers T, Reissmann T, Schmidt M, et al. 2-Aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors. Cancer Res 2002;62:3113-3119.
-
(2002)
Cancer Res
, vol.62
, pp. 3113-3119
-
-
Beckers, T.1
Reissmann, T.2
Schmidt, M.3
-
45
-
-
0034770411
-
Synthesis and characterization of the biologically active 2-[1-(4-chlorobenzyl)- 1H-indol-3-yl]-2-oxo-N-pyridin-4-yl acetamide
-
Knaack M, Emig P, Bats JW, Kiesel M, Müller A, Günther E. Synthesis and characterization of the biologically active 2-[1-(4-chlorobenzyl)- 1H-indol-3-yl]-2-oxo-N-pyridin-4-yl acetamide. Eur J Org Chem 2001;20:3843-3847.
-
(2001)
Eur J Org Chem
, vol.20
, pp. 3843-3847
-
-
Knaack, M.1
Emig, P.2
Bats, J.W.3
Kiesel, M.4
Müller, A.5
Günther, E.6
-
46
-
-
33847112666
-
Indol-3-yl-glyoxylsäure-derivate mit antitumorwirkung
-
Patent WO 51224
-
Nickel B, Szelenyi S, Schmidt J, Emig P, Reichert D, Günther E, Brune K. Indol-3-yl-glyoxylsäure-derivate mit antitumorwirkung. Patent WO 51224, 1999.
-
(1999)
-
-
Nickel, B.1
Szelenyi, S.2
Schmidt, J.3
Emig, P.4
Reichert, D.5
Günther, E.6
Brune, K.7
-
47
-
-
0035133804
-
D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vitro, shows efficacy toward multidrug-resistant tumor cells, and lacks neutoxicity
-
Bacher G, Nickel B, Emig P, Vanhofer U, Seeber S, Shandra A, Klenner T, Beckers T. D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vitro, shows efficacy toward multidrug-resistant tumor cells, and lacks neutoxicity. Cancer Res 2001;61:392-399.
-
(2001)
Cancer Res
, vol.61
, pp. 392-399
-
-
Bacher, G.1
Nickel, B.2
Emig, P.3
Vanhofer, U.4
Seeber, S.5
Shandra, A.6
Klenner, T.7
Beckers, T.8
-
48
-
-
0037030605
-
One-pot synthesis of benzo[b]furan and indole inhibitors of tubulin polymerization
-
Flynn BL, Hamel E, Jung MK. One-pot synthesis of benzo[b]furan and indole inhibitors of tubulin polymerization. J Med Chem 2002;45:2670-2673.
-
(2002)
J Med Chem
, vol.45
, pp. 2670-2673
-
-
Flynn, B.L.1
Hamel, E.2
Jung, M.K.3
-
49
-
-
0026769043
-
A versatile approach to 2,3-disubstituted indoles through the palladium-catalyzed cyclization of o-alkynylfluoroacetanilides with vinyl triflates and aryl halides
-
Arcadi A, Cacchi S, Marinelli F. A versatile approach to 2,3-disubstituted indoles through the palladium-catalyzed cyclization of o-alkynylfluoroacetanilides with vinyl triflates and aryl halides. Tetrahedron 1992;33:3915-3918.
-
(1992)
Tetrahedron
, vol.33
, pp. 3915-3918
-
-
Arcadi, A.1
Cacchi, S.2
Marinelli, F.3
-
50
-
-
0028118842
-
2-Substituted-3- acylindoles through the palladium-catalyzed carbonilative cyclization of 2-alkynyltrifuoroacetanilides with aryl halides anf vinyl triflates
-
Arcadi A, Cacchi S, Carnicelli V, Marinelli F. 2-Substituted-3- acylindoles through the palladium-catalyzed carbonilative cyclization of 2-alkynyltrifuoroacetanilides with aryl halides anf vinyl triflates. Tetrahedron 1994;50:437-452.
-
(1994)
Tetrahedron
, vol.50
, pp. 437-452
-
-
Arcadi, A.1
Cacchi, S.2
Carnicelli, V.3
Marinelli, F.4
-
51
-
-
3843136376
-
Coincise synthesis and structure-activity relationships of combretastatins A-4 analogues, 1-aroylindoles and 3-aroylindoles, a novel class of potent antitubulin agents
-
Liou J-P, Chang Y-C, Kuo F-M, Chang C-W, Tseng H-Y, Wang C-C, Yang Y-N, Chang J-Y, Lee S-J, Hsieh HP. Coincise synthesis and structure-activity relationships of combretastatins A-4 analogues, 1-aroylindoles and 3-aroylindoles, a novel class of potent antitubulin agents. J Med Chem 2004;47:4247-4257.
-
(2004)
J Med Chem
, vol.47
, pp. 4247-4257
-
-
Liou, J.-P.1
Chang, Y.-C.2
Kuo, F.-M.3
Chang, C.-W.4
Tseng, H.-Y.5
Wang, C.-C.6
Yang, Y.-N.7
Chang, J.-Y.8
Lee, S.-J.9
Hsieh, H.P.10
-
52
-
-
2442639013
-
Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents
-
Liou J-P, Chang J-Y, Chang C-W, Chang CY, Mahindroo N, Kuo FM, Hsieh HP. Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents. J Med Chem 2004;47:2897-2905.
-
(2004)
J Med Chem
, vol.47
, pp. 2897-2905
-
-
Liou, J.-P.1
Chang, J.-Y.2
Chang, C.-W.3
Chang, C.Y.4
Mahindroo, N.5
Kuo, F.M.6
Hsieh, H.P.7
-
53
-
-
3042740981
-
BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral acitivity in vivo
-
Kuo C-C, Hsieh H-P, Pan W-Y, Chen C-P, Liou J-P, Lee S-J, Chang Y-L, Chen LT, Chen C-T, Chang J-Y. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral acitivity in vivo. Cancer Res 2004;64:4621-4628.
-
(2004)
Cancer Res
, vol.64
, pp. 4621-4628
-
-
Kuo, C.-C.1
Hsieh, H.-P.2
Pan, W.-Y.3
Chen, C.-P.4
Liou, J.-P.5
Lee, S.-J.6
Chang, Y.-L.7
Chen, L.T.8
Chen, C.-T.9
Chang, J.-Y.10
-
54
-
-
10044236627
-
Arylthioindoles, potent inhibitors of tubulin polymerization
-
De Martino G, La Regina G, Coluccia A, Edler MC, Barbera MC, Brancale A, Wilcox E, Hamel E, Artico M, Silvestri R. Arylthioindoles, potent inhibitors of tubulin polymerization. J Med Chem 2004;47:6120-6123.
-
(2004)
J Med Chem
, vol.47
, pp. 6120-6123
-
-
De Martino, G.1
La Regina, G.2
Coluccia, A.3
Edler, M.C.4
Barbera, M.C.5
Brancale, A.6
Wilcox, E.7
Hamel, E.8
Artico, M.9
Silvestri, R.10
-
55
-
-
0035801759
-
The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4
-
Flynn BL, Flynn GP, Hamel E, Jung MK. The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4. Bioorg Med Chem Lett 2001;11:2341-2343.
-
(2001)
Bioorg Med Chem Lett
, vol.11
, pp. 2341-2343
-
-
Flynn, B.L.1
Flynn, G.P.2
Hamel, E.3
Jung, M.K.4
-
56
-
-
0037030605
-
One-pot synthesis of benzo[b]furan and indole inhibitors of tubulin polymerization
-
Flynn BL, Hamel E, Jung MK. One-pot synthesis of benzo[b]furan and indole inhibitors of tubulin polymerization. J Med Chem 2002;45:2670-2673.
-
(2002)
J Med Chem
, vol.45
, pp. 2670-2673
-
-
Flynn, B.L.1
Hamel, E.2
Jung, M.K.3
-
57
-
-
0031860599
-
Phase I study of E7010
-
Yamamoto K, Noda K, Yoshimura A, Kukuoka M, Furuse K, Niitani H. Phase I study of E7010. Cancer Chem Pharmacol 1998;42:124-134.
-
(1998)
Cancer Chem Pharmacol
, vol.42
, pp. 124-134
-
-
Yamamoto, K.1
Noda, K.2
Yoshimura, A.3
Kukuoka, M.4
Furuse, K.5
Niitani, H.6
-
59
-
-
32344432249
-
New arythioindoles, potent inhibitors of tubulin polymerization. 2. Structure activity relationship and molecular modeling studies
-
De Martino G, Edler MC, La Regina G, Coluccia A, Barbera MC, Barrow D, Nicholson RI, Chiosis G, Brancale A, Hamel E, Artico M, Silvestri R. New arythioindoles, potent inhibitors of tubulin polymerization. 2. Structure activity relationship and molecular modeling studies. J Med Chem 2006;49:947-954.
-
(2006)
J Med Chem
, vol.49
, pp. 947-954
-
-
De Martino, G.1
Edler, M.C.2
La Regina, G.3
Coluccia, A.4
Barbera, M.C.5
Barrow, D.6
Nicholson, R.I.7
Chiosis, G.8
Brancale, A.9
Hamel, E.10
Artico, M.11
Silvestri, R.12
-
60
-
-
1642401199
-
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
-
Ravelli RBG, Gigant B, Curmi PA, Jourdain I, Lachkar S, Sobel A, Knossow M. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature 2004;428:198-202.
-
(2004)
Nature
, vol.428
, pp. 198-202
-
-
Ravelli, R.B.G.1
Gigant, B.2
Curmi, P.A.3
Jourdain, I.4
Lachkar, S.5
Sobel, A.6
Knossow, M.7
|